India  

"Sun Pharma"

Latest news and video coverage curated from trusted media outlets

You Might Like

Sudarshan Sukhani: BUY Bandhan Bank, Reliance, Sun Pharma, Muthoot Finance; SELL IEX


TopNews - Published

Sensex, Nifty rebound nearly 1% on gains in auto, IT stocks

From the Sensex pack, Maruti, M&M, Asian Paints, Bharti Airtel, TCS, Sun Pharma, Wipro, ICICI Bank and Hindustan Unilever were the major gainers.
Zee News - Published

Mitessh Thakkar: BUY NTPC, Bosch, Zee; SELL Sun Pharma


TopNews - Published

Kushal Gupta: BUY Infosys; SELL Sun Pharma, SBI and Hindalco


TopNews - Published

Sun Pharma shares tumble over 4% post Q4 earnings

Shares of Sun Pharmaceutical Industries fell by over 4 per cent in morning trade on Tuesday a day after the company said its consolidated net loss stood at Rs 2,277 crore for the fourth quarter ended..
IndiaTimes - Published

Ashish Chaturvedi: BUY Kotak Mahindra Bank, Kajaria Ceramics, Sun Pharma; SELL HCL Technologies


TopNews - Published

Sun Pharma tanks on USFDA observations on Halol plant

Sun Pharma announced on Tuesday the US drugs regulator, US Food and Drug Administration has issued a 'Form 483', after inspecting its Halol facility in Gujarat. The action led to a near 3% fall in the..
IndiaTimes - Published

Sudarshan Sukhani: BUY Asian Paints, PFC, M&M Finance; SELL Sun Pharma


TopNews - Published

Shrikant Chouhan: BUY SBI, Reliance Industries, ICICI Bank, Sun Pharma and Fortis


TopNews - Published

Sudarshan Sukhani: BUY SBI Cards, AU Small Bank, Pidilite; SELL Sun Pharma


TopNews - Published

Mitessh Thakkar: BUY Berger Paints, Dabur India, L&T and Sun Pharma


TopNews - Published

Sudarshan Sukhani: BUY Sun Pharma, Axis Bank, SRF; SELL Godrej Consumer


TopNews - Published

Sensex closes 85 points higher in choppy trade; Tata Steel, Sun Pharma surge


newKerala.com - Published

Sensex rises points 85; Nifty ends above 18,250

Tata Steel was the top gainer in the Sensex pack, jumping over 6 per cent, followed by Sun Pharma, L&T, M&M, PowerGrid, Bajaj Finserv, TCS and Infosys.
Zee News - Published

Covid antiviral pill launched at 1,399 for full 5-day course

Over a dozen companies, including Hetero, Sun Pharma, Natco and Dr Reddy’s are in the process of rolling out the oral therapy developed by Merck and and its partner, Ridgeback Biotherapeutics, at..
IndiaTimes - Published

Sensex ends 296 points higher; Nifty tops 17,050

Tech Mahindra was the top gainer in the Sensex pack, rising over 3 per cent, followed by Dr Reddy's, PowerGrid, Kotak Bank, Sun Pharma, ICICI Bank and M&M.
Zee News - Published

Ashish Chaturvedi: BUY Sun Pharma, India Cements, Finolex Industries and HCL Technologies


TopNews - Published

Mitesh Thakkar: BUY Sun Pharma, Lupin, Granules India and Amara Raja Batteries


TopNews - Published

Ashish Chaturvedi: BUY Bajaj Holdings, Globus Spirits and Fortis Healthcare; SELL Sun Pharma


TopNews - Published

SABERA Awards Jury Led by HDFC MD Renu Sud Karnad Enters Final Round of Winner Selection

sabera awards jury led by hdfc md renu sud karnad enters final round of winner selection
· The SABERA Awards jury, led by Renu Sud Karnad, MD HDFC Ltd., comprises 10 leaders from the corporates, civil and nonprofit sectors · The three main award categories acknowledge SDG and ESG..
NewsVoir - Published

Mitesh Thakkar: BUY Sun Pharma, Mahindra & Mahindra and ABFRL; SELL Larsen & Toubro


TopNews - Published

Mitesh Thakkar: BUY Hero MotoCorp; SELL Vedanta, JSW Steel and Sun Pharma


TopNews - Published

Sun Pharma comes out of red in Q1


IndiaTimes - Published

Sun Pharma posts Rs 1,444.17 crore net profit in June quarter

Drug major Sun Pharmaceutical Industries on Friday reported a net profit of Rs 1,444.17 crore for the quarter ended June 30, 2021. The company had posted a net loss of Rs 1,655.60 crore for the..
IndiaTimes - Published Also reported by •newKerala.com

Sensex drops over 100 pts in early trade; Nifty slips below 15,800

L&T was the top loser in the Sensex pack, shedding around 1 per cent, followed by Sun Pharma, Bajaj Finance, HDFC Bank and Kotak Bank.
Mid-Day - Published Also reported by •Zee News

Sudarshan Sukhani: BUY UPL, Sun Pharma, SELL Adani Ports and Zee


TopNews - Published

Sensex, Nifty rebound in line with Asian peers; financial stocks shine

On the Sensex chart, ICICI Bank was the top gainer, surging 2.83 per cent, followed by HDFC, Axis Bank, Sun Pharma, NTPC and M&M.
Zee News - Published

Mitesh Thakkar: BUY IGL; SELL Sun Pharma, Aurobindo Pharma and City Union Bank


TopNews - Published

Mitesh Thakkar: BUY Deepak Nitrite, Dr Reddy’s, Sun Pharma; SELL JSW Steel


TopNews - Published

Sun Pharma settles patent dispute with US Celgene Corporation


newKerala.com - Published

Sun Pharma Q4 profit zooms over two-fold to Rs 894.15cr

Drug major Sun Pharmaceutical Industries on Thursday reported an over two-fold jump in consolidated net profit to Rs 894.15 crore for the quarter ended March 2021, mainly on account of robust..
IndiaTimes - Published

Sensex opens over 150 pts higher, turns red amid weak global cues

ONGC was the top loser in the Sensex pack, shedding around 2 per cent, followed by Sun Pharma, Axis Bank, PowerGrid, Bajaj Finance and Nestle India.
Mid-Day - Published

Sensex rallies 848 pts; Nifty ends above 14,900 led by financial stocks

IndusInd Bank was the top gainer in the Sensex pack, rallying over 7 percent, followed by SBI, ICICI Bank, HDFC twins, Axis Bank, Bajaj Finserv, and UltraTech Cement. On the other hand, L&T, Bharti..
Zee News - Published

Mumbai: Sensex jumps 296 points, pharma stocks surge

mumbai: sensex jumps 296 points, pharma stocks surge
Among stocks, Coal India moved up by 8 per cent to Rs 148.10 per share. Pharma majors Dr Reddy`s and Sun Pharma were up by 3 per cent and 2.7 per cent respectively.
Mid-Day - Published

Lilly signs pacts with Cipla, Lupin, Sun Pharma to accelerate availability of baricitinib for Covid-19 patients


newKerala.com - Published

Eli Lilly signs agreements with Cipla, Lupin and Sun Pharma


newKerala.com - Published

Shrikant Chouhan: BUY Sun Pharma, JSW Steel, Vedanta and Cadila HealthCare


TopNews - Published

Sensex ends 465 points lower, Nifty slips below 14,500 amid lockdown and IPL suspension

The 30-share BSE index ended 465.01 points or 0.95 percent lower at 48,253.51, and the broader NSE Nifty slumped 137.65 points or 0.94 percent to 14,496.50. Dr Reddy's was the top loser in the Sensex..
Zee News - Published